Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Microorganisms in Medicine and Therapeutics

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.

iPS Cell Differentiation

iPS Cell Differentiation

The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.

Stem Cell Culture

Stem Cell Culture

Stem cell research aims to find ways to use stem cells to regenerate and repair cellular damage. Over time, most adult cells undergo the wear and tear of aging and lose their ability to divide and repair themselves. Stem cells do not display a particular morphology or function. Adult stem cells, which exist as a small subset of cells in most tissues, keep dividing and can differentiate into a number of specialized cells generally formed by that tissue. These cells enable the body to renew and...

Mesenchymal Stem Cells

Mesenchymal Stem Cells

Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their access...

Stem Cell Therapy for Tissue Regeneration

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...

Forced Transdifferentiation

Forced Transdifferentiation

Transdifferentiation, also known as lineage reprogramming, was first discovered by Selman and Kafatos in 1974 in silkmoths. They observed that the moths’ cuticle-producing cells transformed into salt-producing cells. Many such cases of natural transdifferentiation occur in organisms. In humans, pancreatic alpha cells can become beta cells. In newts, the loss of the eye’s lens causes the pigmented epithelial cells to transdifferentiate into the lens cells.
Artificial transdifferentiation occurs...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Outcome of Standardbred racehorses following femoropatellar arthroscopy for osteochondrosis dissecans.

Veterinary surgery : VS·2025

Same author

How Illinois increased students' clinical exposure by 50.

Journal of the American Veterinary Medical Association·2022

Same author

Kinetic Analysis in Horses With Deep Digital Flexor Tendinopathy Within the Digit Diagnosed by Magnetic Resonance Imaging.

Frontiers in veterinary science·2022

Same author

Performance of predictive models of survival in horses undergoing emergency exploratory laparotomy for colic.

Veterinary surgery : VS·2022

Same author

Retroviral association with ovarian adenocarcinoma in laying hens.

Avian pathology : journal of the W.V.P.A·2021

Same author

Ex vivo effects of corticosteroids on equine deep digital flexor and navicular fibrocartilage explant cell viability.

American journal of veterinary research·2021

Same journal

Pharmaceutical and Nutraceutical Therapies for Liver Disease.

The Veterinary clinics of North America. Equine practice·2026

Same journal

Clinical Signs of Liver Disease in Horses.

The Veterinary clinics of North America. Equine practice·2026

Same journal

Syndrome of High Gamma-Glutamyl Transferase in Racehorses.

The Veterinary clinics of North America. Equine practice·2026

Same journal

Equine Hepatology in Practice: Insights, Challenges, and Progress.

The Veterinary clinics of North America. Equine practice·2026

Same journal

Pathophysiology and Treatment of Hepatic Encephalopathy.

The Veterinary clinics of North America. Equine practice·2026

Same journal

Viral Hepatitis.

The Veterinary clinics of North America. Equine practice·2026

See all related articles

Search research articles

Related Experiment Video

Updated: May 29, 2026

Human Mesenchymal Stem Cell Processing for Clinical Applications Using a Closed Semi-Automated Workflow

Human Mesenchymal Stem Cell Processing for Clinical Applications Using a Closed Semi-Automated Workflow

Published on: March 17, 2023

Cell-based therapies: current issues and future directions.

Matthew C Stewart¹

¹Department of Veterinary Clinical Medicine, College of Veterinary Medicine, University of Illinois, 1008 West Hazelwood Drive, Urbana, IL 61802, USA. matt1@illinois.edu

The Veterinary Clinics of North America. Equine Practice

|August 30, 2011

Summary

This summary is machine-generated.

This review explores stem cell therapy challenges in horses, focusing on mesenchymal stem cell (MSC) sources, allogeneic products, and efficacy validation for musculoskeletal conditions.

More Related Videos

In Vivo Osteo-organoid Approach for Harvesting Therapeutic Hematopoietic Stem/Progenitor Cells

In Vivo Osteo-organoid Approach for Harvesting Therapeutic Hematopoietic Stem/Progenitor Cells

Published on: February 16, 2024

Automated Cell Enrichment of Cytomegalovirus-specific T cells for Clinical Applications using the Cytokine-capture System

Automated Cell Enrichment of Cytomegalovirus-specific T cells for Clinical Applications using the Cytokine-capture System

Published on: October 5, 2015

Related Experiment Videos

Last Updated: May 29, 2026

Human Mesenchymal Stem Cell Processing for Clinical Applications Using a Closed Semi-Automated Workflow

Human Mesenchymal Stem Cell Processing for Clinical Applications Using a Closed Semi-Automated Workflow

Published on: March 17, 2023

In Vivo Osteo-organoid Approach for Harvesting Therapeutic Hematopoietic Stem/Progenitor Cells

In Vivo Osteo-organoid Approach for Harvesting Therapeutic Hematopoietic Stem/Progenitor Cells

Published on: February 16, 2024

Automated Cell Enrichment of Cytomegalovirus-specific T cells for Clinical Applications using the Cytokine-capture System

Automated Cell Enrichment of Cytomegalovirus-specific T cells for Clinical Applications using the Cytokine-capture System

Published on: October 5, 2015

Area of Science:

Equine medicine
Regenerative medicine
Biologic therapies

Background:

Cell-based therapies, particularly stem cells, show promise for equine musculoskeletal conditions.
Current applications face challenges in standardization and efficacy demonstration.

Purpose of the Study:

To review current issues and future directions for cell-based therapies in equine practice.
To discuss the validation of stem cells and related biologics for equine musculoskeletal disorders.

Main Methods:

Literature review of current research on equine cell-based therapies.
Discussion of key challenges including cell sourcing, allogeneic products, and regulatory aspects.
Exploration of technical considerations for cell-based biologic agents and MSC homing.

Main Results:

Identified challenges in characterizing tissue-specific mesenchymal stem cell (MSC) sources.
Discussed feasibility of allogeneic stem cell products and advantages of minimally manipulated biologics.
Highlighted the need for robust logistics to demonstrate cell-based therapy efficacy in horses.

Conclusions:

Further research is needed to overcome current hurdles in equine cell-based therapy.
Standardization of cell products and rigorous efficacy studies are crucial for clinical adoption.
Exploring non-orthopaedic applications and optimizing MSC homing will advance the field.